What is Latch Bio?
Latch Bio is at the forefront of the biocomputing revolution, developing essential data infrastructure for the scientific community. Its cloud-based platform empowers scientists to effortlessly store, transform, and visualize biological data through any web browser. This innovative approach democratizes access to popular bioinformatics pipelines and data visualization tools, enabling global researchers to accelerate discovery and innovation without requiring extensive coding expertise. The company's mission is to build and disseminate the foundational data infrastructure necessary for the next wave of biological advancements.
How much funding has Latch Bio raised?
Latch Bio has raised a total of $33M across 2 funding rounds:
Angel/Seed
$5M
Series A
$28M
Angel/Seed (2021): $5M with participation from Haystack, General Catalyst, and Lux Capital
Series A (2022): $28M led by Lux Capital, Coatue, Haystack, Fifty Years, Caffeinated Capital, and Hummingbird Ventures
Key Investors in Latch Bio
Lux Capital
Lux Capital is a venture capital firm specializing in early-stage and growth-stage companies at the intersection of science and technology, with a focus on areas like AI, robotics, space, defense, biotechnology, and advanced materials.
General Catalyst
General Catalyst is a venture capital firm that identifies and supports transformational business opportunities across multiple sectors and stages, backing entrepreneurs with ambitious visions to reshape industries.
Haystack
Haystack is an early-stage startup focused on leveraging crowd-sourced data to promote local stores and foster a smarter shopping revolution.
What's next for Latch Bio?
With the recent infusion of major strategic capital, Latch Bio is poised for accelerated growth and expansion. This significant investment, part of its $33M in total financing, will likely fuel further development of its no-code bioinformatics platform, enhance its cloud infrastructure, and broaden its reach within the global scientific community. The company's focus on democratizing data access in biocomputing positions it for substantial impact, potentially enabling breakthroughs across various life science disciplines. Future endeavors may include expanding its suite of bioinformatics tools, forging strategic partnerships with research institutions and pharmaceutical companies, and scaling its operations to meet increasing demand.
See full Latch Bio company page
